Publikationen in Zusammenarbeit mit Forschern von University of Münster (58)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2023

  1. 267th ENMC International workshop: psychological interventions for improving quality of life in slowly progressive neuromuscular disorders

    Neuromuscular Disorders

  2. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  3. Lipopolysaccharide-binding protein and future Parkinson’s disease risk: a European prospective cohort

    Journal of Neuroinflammation, Vol. 20, Núm. 1

  4. Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease

    Alzheimer's and Dementia, Vol. 19, Núm. 8, pp. 3350-3364

  5. Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning

    Genome Medicine, Vol. 15, Núm. 1

  6. Prediagnostic Blood Metal Levels and the Risk of Parkinson's Disease: A Large European Prospective Cohort

    Movement Disorders, Vol. 38, Núm. 12, pp. 2302-2307

2021

  1. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

    eLife, Vol. 10

  2. Permissive epigenomes endow reprogramming competence to transcriptional regulators

    Nature Chemical Biology, Vol. 17, Núm. 1, pp. 47-56

2020

  1. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

    Acta Neuropathologica

  2. Reprogramming competence of OCT factors is determined by transactivation domains

    Science Advances, Vol. 6, Núm. 36

2019

  1. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

    Acta Neuropathologica, Vol. 138, Núm. 2, pp. 237-250

  2. Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease

    Hepatology, Vol. 69, Núm. 2, pp. 699-716

  3. Rising rural body-mass index is the main driver of the global obesity epidemic in adults

    Nature

  4. Sediment Respiration Pulses in Intermittent Rivers and Ephemeral Streams

    Global Biogeochemical Cycles, Vol. 33, Núm. 10, pp. 1251-1263

2018

  1. Esrrb Unlocks Silenced Enhancers for Reprogramming to Naive Pluripotency

    Cell Stem Cell, Vol. 23, Núm. 2, pp. 266-275.e6

  2. Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation

    Molecular Neurodegeneration, Vol. 13, Núm. 1

  3. Revised roles of ISL1 in a hES cell-based model of human heart chamber specification

    eLife, Vol. 7

  4. Rules governing the mechanism of epigenetic reprogramming memory

    Epigenomics, Vol. 10, Núm. 2, pp. 149-174

2017

  1. Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein

    Scientific Reports, Vol. 7